RESULTS	Treatment-emergent adverse events ( 5 % with LDX ) during the 4-week dose-optimization phase were decreased appetite , dry mouth , headache , insomnia , upper respiratory tract infection , irritability , nausea , anxiety , and feeling jittery .\